Stock listing

NASDAQ:MRSN Mersana Therapeutics Inc Stock

Follow Mersana Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:MRSN

$29.04 USD

Close on Jan 2, 2026 · No longer trades

Jul 28, 2025 to last close +325.2% · daily closes, Jul 28, 2025 – Jan 2, 2026
Lowest – highest close
$5.97 – $29.10 USDSince Jul 28, 2025 · lowest Aug 11, 2025 · highest Dec 18, 2025

Delisted NASDAQ:MRSN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:MRSN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Mersana Therapeutics Inc on 6ix

Calls
17 calls with a replay · 17 with a transcript · latest Aug 13, 2025
Decks
6 decks · latest Aug 13, 2025

Events

CallWhenStatus
Mersana Therapeutics (MRSN) Q2 2025 Earnings CallWed, Aug 13, 2025 · 8:00 AM ETReplay
Mersana Therapeutics (MRSN) Q1 2025 Earnings CallThu, May 15, 2025 · 8:00 AM ETReplay
Mersana Therapeutics (MRSN) Q4 2024 Earnings CallMon, Mar 03, 2025 · 8:30 AM ETReplay
Mersana Therapeutics (MRSN) Q3 2024 Earnings CallWed, Nov 13, 2024 · 8:00 AM ETReplay
Mersana Therapeutics (MRSN) Q2 2024 Earnings CallTue, Aug 13, 2024 · 8:00 AM ETReplay
Mersana Therapeutics (MRSN) Q1 2024 Earnings CallThu, May 09, 2024 · 8:00 AM ETReplay
Mersana Therapeutics (MRSN) Q4 2023 Earnings CallWed, Feb 28, 2024 · 8:00 AM ETReplay
Mersana Therapeutics (MRSN) Q3 2023 Earnings CallTue, Nov 07, 2023 · 8:00 AM ETReplay
Mersana Therapeutics (MRSN) Q1 2023 Earnings CallTue, May 09, 2023 · 8:00 AM ETReplay
Mersana Therapeutics (MRSN) Q3 2022 Earnings CallMon, Nov 07, 2022 · 8:00 AM ETReplay
All 17 calls
CallWhenStatus
Mersana Therapeutics (MRSN) Q2 2022 Earnings CallMon, Aug 08, 2022 · 4:30 PM ETReplay
Mersana Therapeutics (MRSN) Q1 2022 Earnings CallMon, May 09, 2022 · 8:00 AM ETReplay
Mersana Therapeutics (MRSN) Q4 2021 Earnings CallMon, Feb 28, 2022 · 8:00 AM ETReplay
Mersana Therapeutics (MRSN) Q3 2021 Earnings CallTue, Nov 09, 2021 · 8:00 AM ETReplay
Mersana Therapeutics (MRSN) Q2 2021 Earnings CallFri, Aug 06, 2021 · 8:00 AM ETReplay
Mersana Therapeutics (MRSN) Q1 2021 Earnings CallMon, May 10, 2021 · 4:30 PM ETReplay
Mersana Therapeutics (MRSN) Q4 2020 Earnings CallFri, Feb 26, 2021 · 8:00 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (August 2025)Investor deck35 slidesAug 13, 2025
Technical Presentation (January 2025)Technical22 slidesJan 10, 2025
Technical Presentation (September 2021)Technical32 slidesSep 10, 2021
Investor Day (January 2021)Investor day53 slidesJan 5, 2021
Investor Presentation (January 2020)Investor deck27 slidesJan 10, 2020
Investor Presentation (February 2019)Investor deck24 slidesFeb 28, 2019

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Andrew A F Hack
Other companies: Nuvalent, Inc. (Director · Jul 28, 2021 – Dec 11, 2024 · Past); Atea Pharmaceuticals, Inc. (Director · Oct 29, 2020 – Nov 3, 2020 · Past); BCLS Acquisition Corp (Chief Financial Officer, Director · Oct 21, 2020 – Oct 26, 2020 · Past); Dynavax Technologies Corporation (Director · Aug 12, 2019 – Aug 8, 2023 · Past); Allena Pharmaceuticals Inc (Director · Jun 8, 2018 – Nov 17, 2020 · Past); Editas Medicine, Inc. (Chief Financial Officer · Feb 2, 2016 – Feb 4, 2019 · Past)
Director · Since at least Jun 27, 2017
Lawrence M. Alleva
Other companies: Galera Therapeutics, Inc. (Director · Since at least Nov 6, 2019); Bright Horizons Family Solutions Inc. (Board Member · Since at least May 12, 2016); Adaptimmune Therapeutics PLC (Chairman and Non-Executive Director · Since at least Jan 1, 2016); Tesaro Inc (Director · Jun 1, 2016 – Jan 22, 2019 · Past); Synlogic Inc (Director · Sep 30, 2015 – Jun 29, 2016 · Past)
Director · Since at least Sep 5, 2017
Willard H. Dere
Other companies: Metagenomi Therapeutics, Inc. (Professor Emeritus, Internal Medicine, University of Utah · Since at least Feb 8, 2024); Seres Therapeutics, Inc. (Director · Since at least Jul 7, 2017); BioMarin Pharmaceutical Inc. (Director · Since at least Jul 15, 2016); Ocera Therapeutics Inc (Director · Oct 26, 2016 – Dec 11, 2017 · Past); Radius Health, Inc. (Director · Nov 1, 2014 – Aug 15, 2022 · Past)
Director · Since at least Mar 19, 2018
Anna Protopapas
Other companies: Nuvalent, Inc. (Director · Since at least Mar 30, 2022); Dicerna Pharmaceuticals Inc (Director · Jan 23, 2019 – Jun 3, 2021 · Past); Bioverativ Inc (Director · Feb 28, 2017 – Mar 8, 2018 · Past); Ariad Pharmaceuticals Inc (Director · Feb 1, 2016 – Feb 16, 2017 · Past)
Director · Since at least Jun 27, 2017
Elaine V. Jones
Other companies: NextCure, Inc. (Director · Since at least May 8, 2019); CytomX Therapeutics, Inc. (Director · Since at least May 1, 2019); Ibere Pharmaceuticals (Director · Feb 25, 2021 – Feb 25, 2021 · Past); Gritstone bio, Inc. (Director · Sep 12, 2019 – Apr 4, 2025 · Past)
Director · Jun 27, 2017 – Jun 27, 2017 · Past
Alejandra Carvajal
Other companies: CytomX Therapeutics, Inc. (Chief Legal Officer · Since at least Aug 3, 2026); Momenta Pharmaceuticals Inc (Chief Legal Officer · Oct 5, 2018 – Oct 1, 2020 · Past); Dare Bioscience, Inc. (VP, General Counsel · Jun 26, 2015 – Jan 5, 2017 · Past)
SVP, Chief Legal Officer · Since at least Apr 26, 2021
Martin H Huber Jr
Other companies: Actuate Therapeutics, Inc. (Director · Since at least May 1, 2026); Syndax Pharmaceuticals, Inc. (Director · Since at least Sep 15, 2021); Xilio Therapeutics, Inc. (PRESIDENT AND HEAD OF R&D · Oct 21, 2021 – Aug 16, 2023 · Past)
President, CEO, Director · Since at least Jan 15, 2021
Donald A Bergstrom
Other companies: Relay Therapeutics, Inc. (President, R&D · Since at least Jul 15, 2020); Fusion Pharmaceuticals Inc (Director · Apr 1, 2021 – Jun 4, 2024 · Past)
Chief Medical Officer · Jun 27, 2017 – Feb 2, 2018 · Past
Wayne Foster
Other companies: Atea Pharmaceuticals, Inc. (EXECUTIVE VP, Chief Accounting Officer · Since at least Oct 29, 2020)
Vice President of Finance · Jun 27, 2017 – Jan 23, 2019 · Past
Arvin YangSVP, Chief Medical Officer · Nov 30, 2020 – Jan 13, 2023 · Past
All 15 people
PersonSeat
Ashish MandeliaVP, Chief Accounting Officer · Since at least Jan 15, 2020
Brian DeSchuytnerSVP, COO & CFO · Since at least Jan 15, 2021
Michael J KaufmanChief Manufacturing Officer · Jan 15, 2021 – Jul 15, 2021 · Past
Mohan BalaSVP, Chief Development · Since at least Sep 5, 2023
Tushar MisraSVP, Chief Manuf. Officer · Aug 16, 2021 – Jan 13, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about Mersana Therapeutics Inc.